# The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma

> **NCT06277791** · PHASE2 · RECRUITING · sponsor: **Hospital of Stomatology, Wuhan University** · enrollment: 35 (estimated)

## Conditions studied

- Clinical IVb Stage Oral Squamous Cell Carcinomas Patients

## Interventions

- **DRUG:** Adebrelimab

## Key facts

- **NCT ID:** NCT06277791
- **Lead sponsor:** Hospital of Stomatology, Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-19
- **Primary completion:** 2025-07-31
- **Final completion:** 2026-07-31
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06277791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06277791, "The Combination of Adebrelimab and TP Regimen for Neoadjuvant Therapy in Patients With Stage IVB Oral Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06277791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*